Oscar Health, Inc. Stock News

Oscar Health, Inc. (NYSE:OSCR ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Cornelia Miller - Vice President of Corporate Development & Investor Relations Mario Sc

Oscar Health went public in March 2021, raising around $1.44 billion in gross proceeds in an IPO. The firm provides health insurance to U.S. consumers and related technologies to businesses and health

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, will release its second quarter 2022 financial r

Oscar Health Inc. (NYSE:OSCR ) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Mario Schlosser - Co-Founder and CEO Cornelia Miller - VP-Corporate Development and IR Scot

Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of 10% and 21.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Oscar's unique offering of easy-to-use consumer-facing insurance.

Futures Surge After 4 Day Rout On Ukraine War Optimism; Cryptos Soar After two days of sheer market insanity, including Monday''s furious plunge and Tuesday''s rollercoaster session, U.S. equity futures jumped after 4 straight days of losses, following European equities higher, as Ukraine optimism won, at least initially, over fears about high inflation and global stagflation as a result of soaring commodity prices, sparking a furious Delta squeeze (as we will show shortly in a subsequent post). At 730am ET, Nasdaq 100 contracts were up 2.1% while S&P 500 futures gained 1.6%. The underlying benchmark fell for a fourth straight session on Tuesday to close at its lowest since June 2021. Dow futures rose 1.5%. A bond selloff extended as investor focus turned to upcoming central-bank rate decisions, while oil prices reversed a rally driven by President Joe Biden’s ban on fossil-fuel imports from Russia. . The dollar weakened for the first time in five days, as haven demand waned. Bitcoin soared more than 10% over $42,000 spurred by optimism about an impending U.S. overhaul of crypto oversight that Treasury Secretary Janet Yellen called “historic.” Investors are bracing for a global stagflationary shock from a commodity-price rally fueled by Russia’s isolation even as supply disruptions threaten to usher in a period of slower global growth.

Oscar Health (OSCR) is trading ~4% lower in the post-market Tuesday after the health insurer announced the resignation of Meghan Joyce as Chief Operating Officer of the company…

Oscar Health Inc - Class A (OSCR) shares closed today 10.4% higher than it did at the end of yesterday. The stock is currently down 15.3% year-to-date, down 80.9% over the past 12 months, and down 80.9% over the past five years. Today, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 1.6%. Trading Activity Shares traded as high as $7.50 and as low as $6.23 this week.Shares closed 80.2% below its 52-week high and 28.3% above its 52-week low.Trading volume this week was 33.3% higher than the 10-day average and 42.5% higher than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 380.9% The company's stock price performance over the past 12 months lags the peer average by 738.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Upgrades According to Mizuho, the prior rating for Murphy Oil Corp (NYSE: MUR ) was changed from Neutral to Buy. In the fourth quarter, Murphy Oil showed an EPS of $0.40, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $35.31 and a 52-week-low of $13.51. At the end of the last trading period, Murphy Oil closed at $34.48. For Goodyear Tire & Rubber Co (NASDAQ: GT ), Nomura Instinet upgraded the previous rating of Reduce to Neutral. Goodyear Tire & Rubber earned $0.57 in the fourth quarter, compared to $0.44 in the year-ago quarter. The current stock performance of Goodyear Tire & Rubber shows a 52-week-high of $24.89 and a 52-week-low of $13.45. Moreover, at the end of the last trading period, the closing price was at $15.78. Also check out: 4 Penny Stocks Insiders Are Buying B of A Securities upgraded the previous rating for Bloom Energy Corp (NYSE: BE ) from Neutral to Buy. For the fourth quarter, Bloom Energy had an EPS of $0.05, compared to year-ago quarter EPS of $0.08.

Within the last quarter, Oscar Health (NYSE: OSCR ) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 3 2 0 1 Last 30D 0 1 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 2 1 0 0 3M Ago 0 0 0 0 1 In the last 3 months, 6 analysts have offered 12-month price targets for Oscar Health. The company has an average price target of $12.25 with a high of $20.00 and a low of $6.50. Below is a summary of how these 6 analysts rated Oscar Health over the past 3 months. The greater the number … Full story available on Benzinga.com

Gainers: Orphazyme ORPH +22%. Y-mAbs Therapeutics YMAB +11%. Oscar Health (OSCR) +9%. Theravance Biopharma TBPH +9%. VistaGen Therapeutics (VTGN) +8%.Losers: ProQR Therapeutics PRQR -72%

Oscar Health Inc. (OSCR) CEO Mario Schlosser on Q4 2021 Results - Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--Health insurtech company Oscar Health, Inc. (NYSE: OSCR) today announced its financial results for the fourth quarter and year ended December 31, 2021. We had a strong performance in Q421 and are pleased to have met or exceeded all of our expectations across key metrics, including Medical Loss Ratio and EBITDA said Mario Schlosser, CEO and Co-Founder of Oscar. Our historic growth during Open Enrollment signifies that our tech-enabled member-centric strategy and bra